← FDA DRUG APPROVALS

FDA ANDA · ANDA218034

DOXYCYCLINE

Sponsor: DR REDDYS

APPLICATION
ANDA218034
TYPE
ANDA
ORIGINAL APPROVAL
2024-04-08
LATEST ACTION
2025-09-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DOXYCYCLINEPrescription
DOXYCYCLINE 40MG · CAPSULE · ORAL

Approval history

2025-09-22Labeling · Supplement 1 · standardAP
2024-04-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →